Skin & Soft Tissue Diseases

Researchers present positive new data from multiple studies of VIBATIV at the 2018 ECCMID conference in Madrid, Spain.

New agents are in development, but none represent a magic bullet for the problems that CRE infections present.

A review of the current literature and future directions.

This breakthrough vaccine is quickly becoming an integral part of the adult immunization arsenal.

Paratek’s omadacycline moves another step toward approval.

The results of a new study reveal that hematopoietic cell transplantation (HCT) may still be successful in cases with incomplete radiographic control of invasive fungal infection (IFI) prior to transplant.

The vaccine reduced the risk of herpes zoster by 68.2% in high-risk recipients of hematopoietic stem cell transplant.

Positive safety and efficacy results have been seen across 2 different dosing regimens as well as for any effects on QT prolongation.

An Australian study found patients were better informed and more empowered when they signed up for a national registry of spleen disease patients.

In the wake of Europe’s recent 4-fold increase in measles cases, countries such as Italy, Germany, and Romania are passing tougher laws requiring vaccinations for children being enrolled in school.